SNDL Inc. Files October 2024 Report (6-K)

TL;DR

SNDL filed its October 6-K, including a news release. Keep an eye on disclosures.

AI Summary

SNDL Inc. filed a Form 6-K on October 21, 2024, reporting for the month of October 2024. The filing includes a news release dated October 21, 2024, as Exhibit 99.1. The company previously operated as Sundial Growers Inc. and changed its name on January 31, 2019.

Why It Matters

This filing provides an update on SNDL Inc.'s activities and financial reporting for October 2024, which is important for investors to stay informed about the company's ongoing operations and disclosures.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant new financial information or material events.

Key Players & Entities

• SNDL Inc. (company) — Registrant
• Alberto Paredero Quiros (person) — Chief Financial Officer
• Sundial Growers Inc. (company) — Former company name
• October 21, 2024 (date) — Filing date and news release date

FAQ

From the Filing

0001279569-24-001245.txt : 20241021 0001279569-24-001245.hdr.sgml : 20241021 20241021094027 ACCESSION NUMBER: 0001279569-24-001245 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20241021 FILED AS OF DATE: 20241021 DATE AS OF CHANGE: 20241021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SNDL Inc. CENTRAL INDEX KEY: 0001766600 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39005 FILM NUMBER: 241382207 BUSINESS ADDRESS: STREET 1: 919 11 AVENUE SW STREET 2: SUITE 300 CITY: CALGARY STATE: A0 ZIP: T2R1P3 BUSINESS PHONE: 14039485227 MAIL ADDRESS: STREET 1: 919 11 AVENUE SW STREET 2: SUITE 300 CITY: CALGARY STATE: A0 ZIP: T2R1P3 FORMER COMPANY: FORMER CONFORMED NAME: Sundial Growers Inc. DATE OF NAME CHANGE: 20190131 6-K 1 sndl6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number 001-39005 SNDL INC. (Registrant’s name) #300, 919 - 11 Avenue SW Calgary, AB T2R 1P3 Tel.: (403) 948-5227 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☐ Form 40-F ☒ SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SNDL INC. Date: October 21, 2024 By: /s/ Alberto Paredero Quiros Name: Alberto Paredero Quiros Title: Chief Financial Officer EXHIBIT Exhibit Description of Exhibit 99.1 News Release dated October 21, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED OCTOBER 21, 2024 Exhibit 99.1 SNDL Successfully Completes Privatization of Nova and Welcomes New Director CALGARY, AB, Oct. 21, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) (" SNDL ") and Nova Cannabis Inc. (TSX: NOVC) (" Nova ") are pleased to announce the closing of the previously announced plan of arrangement (the " Arrangement ") pursuant to which SNDL has acquired all of the issued and outstanding common shares in the capital of Nova (" Nova Shares ") not already owned by SNDL, representing approximately 34.8% of the Nova Shares. The Arrangement was approved by at least two-thirds of the holders of Nova Shares (" Nova Shareholders ") and the majority of disinterested Nova Shareholders under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions at a special meeting of the Nova Shareholders on October 16, 2024. The Court of King's Bench of Alberta granted a final order approving the Arrangement on October 17, 2024. All financial information in this press release is reported in Canadian dollars unless otherwise indicated. Pursuant to the Arrangement, each Nova Shareholder (other than SNDL and its affiliates that hold Nova Shares) will receive $1.75 in cash for each Nova Share (the " Cash Consideration "), representing a premium of 41.2% to the 20-day volume weighted average trading price of Nova Shares on the Toronto Stock Exchange (the " TSX ") as of market close on August 12, 2024, the date prior to the announcement of the Arrangement, other than Nova Shareholders that validly elected to receive, in lieu of the Cash Consideration, 0.58 of a common share of SNDL (" SNDL Shares ") for each Nova Share (the " Share Consideration " and, collectively with the Cash Consideration, the " Consideration "), subject to proration and a maximum of 50% of the aggregate Consideration being payable in SNDL Shares. Nova Shareholders representing a total of 275,50